ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,944, issued on May 12, was assigned to Ambrx Inc. (La Jolla, Calif.). "Compositions containing, methods involving, and uses of non-natural a... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,945, issued on May 12, was assigned to OrthoTrophix Inc. (Oakland, Calif.). "Hard tissue therapeutics" was invented by Yoshinari Kumagai (Fo... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,946, issued on May 12. "HLA-DR/CII peptide complexes for treating arthritis" was invented by Nhu-Nguyen Do (Langen, Germany), Vilma Urbonavi... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,947, issued on May 12, was assigned to PEPTRON INC. (Daejeon, South Korea). "Pharmaceutical composition for treating levodopa-induced dyskin... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,948, issued on May 12, was assigned to SUN PHARMACEUTICAL INDUSTRIES Ltd. (Mumbai, India). "GLP-1/GIP dual agonists" was invented by Rajaman... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,949, issued on May 12, was assigned to Case Western Reserve University (Cleveland) and Invictus Therapeutics (Warwick, R.I.). "Compositions ... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,950, issued on May 12, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Treatment of patients with severe von Willebrand dise... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,951, issued on May 12, was assigned to ProAbtech Co. LTD. (Gwangju, South Korea). "Urate oxidase-albumin conjugate, preparation method there... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,952, issued on May 12, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Formulations comprising recombinant acid Alpha-glucosidase"... Read More
ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,953, issued on May 12, was assigned to Evaxion A/S (Horsholm, Denmark) and Statens Serum Institut (Copenhagen S., Denmark). "Vaccines target... Read More